Brain tumor and gut bacteria study
Part of Brain & nervous system, Cancer clinical trials.
This study looks at how the bacteria in your gut might be linked to brain tumors. Researchers want to collect samples (like stool and tissue) during brain surgery to better understand this connection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having surgery to remove a brain tumor (any type) or you are a healthy volunteer
- You are 18 years of age or older
- You are willing to provide stool samples and other specimens for research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for people (children or adults) who are planning brain surgery to remove tumor tissue. It may help researchers learn about care for brain tumors and how outcomes can be improved.
This study looks at how gut bacteria (the microbiome) may differ in children with brain tumors. Researchers will collect samples before and after surgery to understand the connection between gut health and brain tumors.
This study looks at how bacteria in your gut may affect the growth of small-intestine neuroendocrine tumors. If you are having surgery to remove one of these tumors, the research team will collect samples and data to better understand the link between your gut bacteria and the tumor.
This trial uses a small piece of your brain tumor after surgery to test which drugs might work best for you. It helps doctors find the most effective treatment for your specific tumor.
This study looks at how bacteria in the gut and tumor affect breast cancer in women having surgery. The goal is to learn more about the cancer to improve treatment in the future.
This study looks at how the bacteria in your gut change during cancer treatment (and during some blood stem cell transplants). It may help researchers understand why some people respond differently and guide better future treatment.
Hear when a new Malignant Central Nervous System Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.